Literature DB >> 21934547

Neutron-activated ¹⁵³Sm-ion-exchange resin as a tracer for gastrointestinal scintigraphy.

Chai-Hong Yeong1, Basri Johan Jeet Abdullah, Kwan-Hoong Ng, Lip-Yong Chung, Khean-Lee Goh, Sazilah Ahmad Sarji, Alan Christopher Perkins.   

Abstract

Nuclear medicine techniques are well established for the investigation of gastrointestinal (GI) motility and transit. Ion-exchange resins radiolabelled with ⁹⁹mTc and ¹¹¹In are widely used as nonabsorbable radiopharmaceutical markers, with ¹¹¹In being preferred for whole-gut transit studies. This radionuclide, however, is not produced in many countries and may be expensive when obtained through international shipment. This study describes the use of neutron-activated ¹⁵³Sm-resin as an alternative tracer for use in GI scintigraphic investigation. A measure of 50 mg of stable samarium-152 chloride (¹⁵²SmCl₃) was incorporated into 100 mg of cation-exchange resin and irradiated in a neutron flux of 1 × 10¹³ cm⁻² s⁻¹ for 100 s to achieve an activity of 5 MBq after 66 h. Aliquots of ¹¹¹In-radiolabelled resin (5 MBq) were prepared for comparison of labelling and stability. Radiolabelling efficiencies were obtained by washing resin with distilled water, and the activity lost was measured. The radiolabelled resins were immersed in simulated gastric and intestinal fluid environments, and the retention of ¹⁵³Sm³⁺ and ¹¹¹In³⁺ was measured over a 24 h period. At 66 h after production, 91.15 ± 12.42% of ¹⁵³Sm was bound to the resin after washing in distilled water, whereas radiolabelling with ¹¹¹In achieved 99.96 ± 0.02% efficiency. Both radiolabelled resins demonstrated almost 100% stability in simulated intestinal fluid and >90% stability in artificial gastric juice over 24 h. The performance of neutron-activated ¹⁵³Sm-resin is similar to that of ¹¹¹In-resin and can be used as an alternative tracer for GI transit studies when In is not available.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934547     DOI: 10.1097/MNM.0b013e32834b3ac8

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.

Authors:  Mahboubeh Razavi; Hamed Karimian; Chai Hong Yeong; Sazilah Ahmad Sarji; Lip Yong Chung; Shaik Nyamathulla; Mohamed Ibrahim Noordin
Journal:  Drug Des Devel Ther       Date:  2015-06-19       Impact factor: 4.162

2.  Gamma scintigraphic evaluation of floating gastroretentive tablets of metformin HCl using a combination of three natural polymers in rabbits.

Authors:  Mahboubeh Razavi; Hamed Karimian; Chai Hong Yeong; Lip Yong Chung; Shaik Nyamathulla; Mohamed Ibrahim Noordin
Journal:  Drug Des Devel Ther       Date:  2015-08-06       Impact factor: 4.162

3.  Gastroretentive behavior of orally administered radiolabeled tamarind seed formulations in rabbits validated by gamma scintigraphy.

Authors:  Mahboubeh Razavi; Hamed Karimian; Chai Hong Yeong; Mehran Fadaeinasab; Si Lay Khaing; Lip Yong Chung; Didi Erwandi B Mohamad Haron; Mohamed Ibrahim Noordin
Journal:  Drug Des Devel Ther       Date:  2016-12-19       Impact factor: 4.162

4.  Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities.

Authors:  Nurul Ab Aziz Hashikin; Chai-Hong Yeong; Basri Johan Jeet Abdullah; Kwan-Hoong Ng; Lip-Yong Chung; Rehir Dahalan; Alan Christopher Perkins
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

5.  Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors.

Authors:  Yin-How Wong; Hun-Yee Tan; Azahari Kasbollah; Basri Johan Jeet Abdullah; Rajendra Udyavara Acharya; Chai-Hong Yeong
Journal:  World J Exp Med       Date:  2020-03-30

6.  Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis.

Authors:  Yin How Wong; Hun Yee Tan; Azahari Kasbollah; Basri Johan Jeet Abdullah; Chai Hong Yeong
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.